Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers

International Journal of Cancer

Volumn 87, Issue 3, 2000, Pages 317-321

  Russell, Paul A ^a   Pharoah, Paul D P ^a   De Foy, Karen ^a   Ramus, Susan J ^a   Symmonds, Ian ^b   Wilson, Annie ^b   Scott, Ian ^b   Ponder, Bruce A J ^a   Gayther, Simon A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b DERBY CITY GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; ONCOPROTEIN;

ARTICLE; CONTROLLED STUDY; FEMALE; GENE LOSS; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

BRCA1 PROTEIN; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; FEMALE; GENE DELETION; GENES, BRCA1; HETERODUPLEX ANALYSIS; HUMANS; LOSS OF HETEROZYGOSITY; MUTATION; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RNA, MESSENGER; RNA, NEOPLASM;

EID: 0034256069     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20000801)87:3<317::AID-IJC2>3.0.CO;2-B     Document Type: Article

References (26)

1. BRUGAROLAS, J. and JACKS, T., Double indemnity: p53, BRCA and cancer. Nature (Med.), 3, 721-722 (1997).
2. CATTEAU, A., HARRIS, W.H., XU, C.F. and SOLOMON, E., Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene, 18, 1957-1965 (1999).
3. CHEN, Y.M., CHEN, C.F., RILEY, D.J., ALLRED, D.C., CHEN, P.L., VONHOFF, D., OSBORNE, C.K. and LEE, W.H., Aberrant subcellular localization of BRCA1 in breast cancer. Science, 270, 789-791 (1995).
4. CHEN, Y.M., FARMER, A.A., CHEN, C.F., JONES, D.C., CHEN, P.L. and LEE, W.H., BRCA1 is a 220 kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner. Cancer Res., 56, 3168-3172 (1996).
5. DAVIES, B.R., FINNIGAN, D.S., SMITH, S.K. and PONDER, B.A.J., Administration of gonadotropins stimulates proliferation of normal mouse ovarian surface epithelium. Gynecol. Endocrinol., 13, 75-81 (1999).
6. DOBROVIC, A. and SIMPFENDORFER, D., Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res., 57, 3347-3350 (1997).
7. FOSTER, K.A., HARRINGTON, P., KERR, J., RUSSELL, P., DICIOCCIO, R.A., SCOTT, I.V., JACOBS, I., CHENEVIX-TRENCH, G., PONDER, B.A.J. and GAYTHER, S.A., Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer. Cancer Res., 56, 3622-3625 (1996).
8. FUTREAL, P.A. and 26 OTHERS, BRCA1 mutations in primary breast and ovarian carcinomas. Science, 266, 120-122 (1994).
9. GAYTHER, S.A. and 15 OTHERS, Germline mutations of the BRCA1 gene in breast and ovarian-cancer families provide evidence for a genotype-phenotype correlation. Nature (Genet.), 11, 428-433 (1995).
10. GIBSON, U.E.M., HEID, C.A. and WILLIAMS, P.M., A novel method for real time quantitative RT-PCR. Genome Res., 6, 995-1001 (1996).
11. MANCINI, D.N., RODENHISER, D.I., AINSWORTH, P.J., O'MALLEY, F.P., SINGH, S.M., XING, W.R. and ARCHER, T.K., CPG methylalion within the 5′ regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site. Oncogene, 16, 1161-1169 (1998).
12. MERAJVER, S.D., PHAM, T.M., CADUFF, R.F., CHEN, M., POY, E.L., COONEY, K.A., WEBER, B.L., COLLINS, F.S., JOHNSTON, C. and FRANK, T.S., Somatic mutations in the BRCA1 gene in sporadic ovarian tumors. Nature (Genet.), 9, 439-443 (1995).
13. MIKI, Y. and 44 OTHERS, A strong candidate for the breast and ovarian-cancer susceptibility gene BRCA1. Science, 266, 66-71 (1994).
14. OHTANI-FUJITA, N., FUJITA, T., AOIKE, A., OSIFCHIN, N.E., ROBBINS, P.D. and SAKAI, T., CPG methylation inactivates the promoter activity of the human retinohlastoma tumor-suppressor gene. Oncogene. 8, 1063-1067 (1993).
15. RAO, V.N., SHAO, N.S., AHMAD, M. and REDDY, E.S.P., Antisense RNA to the putative tumor suppressor gene BRCA1 transforms mouse fibroblasts. Oncogene, 12, 523-528 (1996).
16. RICE, J.C., MASSEY-BROWN, K.S. and FUTSCHER, B.W., Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells. Oncogene, 17, 1807-1812 (1998).
17. RUFFNER, H. and VERMA, I.M., BRCA1 is a cell cycle-regulated nuclear phosphoprotein. Proc. nat. Acad. Sci. (Wash.), 94, 7138-7143 (1997).
18. SCULLY, R., GANESAN, S., BROWN, M., DECAPRIO, J.A., CANNISTRA, S.A., FEUNTEUN, J., SCHNITT, S. and LIVINGSTON, D.M., Location of BRCA1 in human breast and ovarian cancer cells. Science, 272, 123-125 (1996).
19. SMITH, S.A., EASTON, D.F., EVANS, D.G.R. and PONDER, B.A.J., Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nature (Genet.), 2, 128-131 (1992).
20. TAKAHASHI, H. and 20 OTHERS, Mutation analysis of the BRCA1 gene in ovarian cancers. Cancer Res., 55, 2998-3002 (1995).
21. TAYLOR, J., LYMBOURA, M., PACE, P.E., AHERN, R.P., DESAI, A.J., SHOUSHA, S., COOMBES, R.C. and ALI, S., An important role for BRCA1 in breast cancer progression is indicated by its loss in a large proportion of non-familial breast cancers. Int. J. Cancer. 79, 334-342 (1998).
22. THOMPSON, M.E., JENSEN, R.A., OBERMILLER, P.S., PAGE, D.L. and HOLT, J.T., Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast-cancer progression. Nature (Genet.), 9, 444-450 (1995).
23. VANNIEKERK, C.C., RAMAEKERS, F.C.S., HANSELAAR, A.G.J.M., ALDEWEIRELDT, J. and POLLS, L.G., Changes in expression of differentiation markers between normal ovarian cells and derived tumours. Amer. J. Pathol., 142, 157-177 (1993).
24. WANG, H.C., SHAO, N.S., DING, Q.M., CUI, J.Q., REDDY, E.S.P. and RAO, V.N., BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin-dependent kinases. Oncogene, 15, 143-157 (1997).
25. WILSON, C.A., PAYTON, M.N., ELLIOTT, G.S., BUAAS, F.W., CAJULIS, E.E., GROSSHANS, D., RAMOS, L., REESE, D.M., SLAMON, D.J. and CALZONE, F.J., Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-Delta 11b. Oncogene, 14, 1-16 (1997).
26. WILSON, C.A. and 14 OTHERS. Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nature (Genet.), 21, 236-240 (1999).